Market closedADR
Quoin Pharmaceuticals Ltd. ADS/$QNRX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Quoin Pharmaceuticals Ltd. ADS
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
Ticker
$QNRX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
4
Website
QNRX Metrics
BasicAdvanced
$6.4M
-
-$2.64
1.81
-
Price and volume
Market cap
$6.4M
Beta
1.81
52-week high
$0.47
52-week low
$0.28
Financial strength
Current ratio
3.022
Quick ratio
2.967
Long term debt to equity
45.459
Total debt to equity
56.485
Management effectiveness
Return on assets (TTM)
-44.13%
Return on equity (TTM)
-135.37%
Valuation
Price to book
0.29
Price to tangible book (TTM)
0.32
Price to free cash flow (TTM)
-0.116
Growth
Earnings per share change (TTM)
-76.94%
3-year earnings per share growth (CAGR)
-80.78%
QNRX News
AllArticlesVideos
Quoin Pharmaceuticals Files U.S. and International Patent Applications for Novel Topical Rapamycin Formulations to Treat Rare Disease Indications
GlobeNewsWire·5 days ago
Quoin Pharmaceuticals Announces Highly Positive ‘Whole Body' Clinical Data from Ongoing Pediatric Netherton Syndrome Study
GlobeNewsWire·1 week ago
Quoin Pharmaceuticals Launches First Episode of “NETHERTON NOW” Video Series to Raise Awareness for Netherton Syndrome
GlobeNewsWire·2 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Quoin Pharmaceuticals Ltd. ADS stock?
Quoin Pharmaceuticals Ltd. ADS (QNRX) has a market cap of $6.4M as of March 09, 2025.
What is the P/E ratio for Quoin Pharmaceuticals Ltd. ADS stock?
The price to earnings (P/E) ratio for Quoin Pharmaceuticals Ltd. ADS (QNRX) stock is 0 as of March 09, 2025.
Does Quoin Pharmaceuticals Ltd. ADS stock pay dividends?
No, Quoin Pharmaceuticals Ltd. ADS (QNRX) stock does not pay dividends to its shareholders as of March 09, 2025.
When is the next Quoin Pharmaceuticals Ltd. ADS dividend payment date?
Quoin Pharmaceuticals Ltd. ADS (QNRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Quoin Pharmaceuticals Ltd. ADS?
Quoin Pharmaceuticals Ltd. ADS (QNRX) has a beta rating of 1.81. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.